Skip to content

Serotyping and antimicrobial susceptibility testing of Salmonella enterica in 2022

Serotyping and antimicrobial susceptibility testing of Salmonella enterica in 2022

The information is for S. enterica culture isolates received during the designated year.

Serotypic name No. tested Sterile site specimens Non-sterile site specimens
Total Not susceptible % Total Not susceptible %
Ciprofloxacin Ceftriaxone Ciprofloxacin Ceftriaxone
Enteritidis 590 116 59.5% 4.3% 474 58.9% 4.6%
I 4:i:- 281 5 60.0% 40.0% 276 48.2% 17.0%
Typhimurium 110 7 85.7% 71.4% 103 71.8% 1.9%
Rissen 57 4 50.0% 0.0% 53 32.1% 0.0%
London 37 0 - - 37 56.8% 2.7%
Derby 40 5 100% 20.0% 35 60.0% 0.0%
Saintpaul 11 0 - - 11 63.6% 9.1%
Goldcoast 42 2 0.0% 0.0% 40 32.5% 2.5%
Typhi 12 8 62.5% 12.5% 4 75.0% 25.0%
Braenderup 4 0 - - 4 50.0% 0.0%
Wandsworth 9 1 0.0% 0.0% 8 75.0% 0.0%
Stanley 51 3 33.3% 0.0% 48 4.2% 2.1%
Bareilly 11 0 - - 11 54.5% 0.0%
Meleagridis 8 0 - - 8 0.0% 0.0%
Weltevreden 28 1 0.0% 0.0% 27 7.4% 3.7%
I 19:g,s,t 0 0 - - 0 - -
Give 0 0 - - 0 - -
Singapore 5 0 - - 5 20.0% 0.0%
Reading 0 0 - - 0 - -
Kentucky 4 0 - - 4 75.0% 25.0%
Others 104 16 31.3% 0.0% 88 38.6% 3.4%


Remarks:

Multiple strains may have been received from the same patient.